Personalis Inc. (04X)
Munich
Closed
Oct 8, 2026
Day's Range
14.3952 wk Range
4.45Overview - 04X - Personalis Inc.
Key Statistics
Valuation
Enterprise Value
-84.29M
P/E (Trailing)
‪-15.91‬
PEG Ratio
‪-0.52‬
Price / Book
‪6.49‬
EV / EBITDA
‪1.18‬
Profitability
Gross Margin
‪21.21%‬
Profit Margin
‪22.65%‬
Operating Margin
‪-116.36%‬
Return on Assets
‪-24.32%‬
Return on Equity
‪-31.11%‬
Ownership
Shares Outstanding
106.36M
Price stats
50-Day Avg
‪13.09‬
200-Day Avg
‪8.87‬
Peers - 04X - Personalis Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 04XMunichPersonalis Inc.+64.96%52-week change-15.92P/E (Trailing)‪22.65%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation Common Stock+56.59%52-week change-65.74P/E (Trailing)‪-20.72%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation+85.89%52-week change-126.15P/E (Trailing)‪50.72%‬Profit Margin
- 1K9MunichCareDx, Inc.+75.91%52-week change-133.75P/E (Trailing)‪67.55%‬Profit Margin
- 5GHMunichGuardant Health Inc.+66.74%52-week change-46.63P/E (Trailing)‪64.46%‬Profit Margin
- ILUMunichIllumina Inc.+66.13%52-week change42.93P/E (Trailing)‪66.08%‬Profit Margin
- NG9MunichNeoGenomics, Inc.+60.31%52-week change-20.24P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - 04X - Personalis Inc.
About
Personalis Inc. is a biotechnology company focused on advanced cancer genomics and precision oncology. Personalis develops and markets genomic tests and sequencing services that help healthcare providers, pharmaceutical companies, biopharma partners, universities, and government organizations analyze tumor and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
